CHINA RESOURCES PHARMACEUTICAL GROUP LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 640 for the last semiannual is 16.66 B EUR, and it's 2.50% higher compared to the previous semiannual. The net income of H1 24 is 337.39 M EUR.